243 related articles for article (PubMed ID: 11880033)
1. Structure-based computational database screening, in vitro assay, and NMR assessment of compounds that target TAR RNA.
Lind KE; Du Z; Fujinaga K; Peterlin BM; James TL
Chem Biol; 2002 Feb; 9(2):185-93. PubMed ID: 11880033
[TBL] [Abstract][Full Text] [Related]
2. Structure of TAR RNA complexed with a Tat-TAR interaction nanomolar inhibitor that was identified by computational screening.
Du Z; Lind KE; James TL
Chem Biol; 2002 Jun; 9(6):707-12. PubMed ID: 12079782
[TBL] [Abstract][Full Text] [Related]
3. Aromatic polyamidines inhibiting the Tat-induced HIV-1 transcription recognize structured TAR-RNA.
Mischiati C; Jeang KT; Feriotto G; Breda L; Borgatti M; Bianchi N; Gambari R
Antisense Nucleic Acid Drug Dev; 2001 Aug; 11(4):209-17. PubMed ID: 11572598
[TBL] [Abstract][Full Text] [Related]
4. Discoveries of Tat-TAR interaction inhibitors for HIV-1.
Yang M
Curr Drug Targets Infect Disord; 2005 Dec; 5(4):433-44. PubMed ID: 16535863
[TBL] [Abstract][Full Text] [Related]
5. An inhibitor of the Tat/TAR RNA interaction that effectively suppresses HIV-1 replication.
Hamy F; Felder ER; Heizmann G; Lazdins J; Aboul-ela F; Varani G; Karn J; Klimkait T
Proc Natl Acad Sci U S A; 1997 Apr; 94(8):3548-53. PubMed ID: 9108013
[TBL] [Abstract][Full Text] [Related]
6. Inhibitors of protein-RNA complexation that target the RNA: specific recognition of human immunodeficiency virus type 1 TAR RNA by small organic molecules.
Mei HY; Cui M; Heldsinger A; Lemrow SM; Loo JA; Sannes-Lowery KA; Sharmeen L; Czarnik AW
Biochemistry; 1998 Oct; 37(40):14204-12. PubMed ID: 9760258
[TBL] [Abstract][Full Text] [Related]
7. Rational design of inhibitors of HIV-1 TAR RNA through the stabilisation of electrostatic "hot spots".
Davis B; Afshar M; Varani G; Murchie AI; Karn J; Lentzen G; Drysdale M; Bower J; Potter AJ; Starkey ID; Swarbrick T; Aboul-ela F
J Mol Biol; 2004 Feb; 336(2):343-56. PubMed ID: 14757049
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of HIV-1 Tat-TAR interaction by diphenylfuran derivatives: effects of the terminal basic side chains.
Gelus N; Bailly C; Hamy F; Klimkait T; Wilson WD; Boykin DW
Bioorg Med Chem; 1999 Jun; 7(6):1089-96. PubMed ID: 10428378
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of HIV-1 replication by anti-trans-activation responsive polyamide nucleotide analog.
Kaushik N; Basu A; Pandey VN
Antiviral Res; 2002 Oct; 56(1):13-27. PubMed ID: 12323396
[TBL] [Abstract][Full Text] [Related]
10. Molecular basis of HIV-1 TAR RNA specific recognition by an acridine tat-antagonist.
Gelus N; Hamy F; Bailly C
Bioorg Med Chem; 1999 Jun; 7(6):1075-9. PubMed ID: 10428376
[TBL] [Abstract][Full Text] [Related]
11. RNA as a target for drug design, the example of Tat-TAR interaction.
Froeyen M; Herdewijn P
Curr Top Med Chem; 2002 Oct; 2(10):1123-45. PubMed ID: 12173971
[TBL] [Abstract][Full Text] [Related]
12. Targeting Tat-TAR RNA Interaction for HIV-1 Inhibition.
Alanazi A; Ivanov A; Kumari N; Lin X; Wang S; Kovalskyy D; Nekhai S
Viruses; 2021 Oct; 13(10):. PubMed ID: 34696435
[TBL] [Abstract][Full Text] [Related]
13. Blocking HIV replication by targeting Tat protein.
Hamy F; Gelus N; Zeller M; Lazdins JL; Bailly C; Klimkait T
Chem Biol; 2000 Sep; 7(9):669-76. PubMed ID: 10980447
[TBL] [Abstract][Full Text] [Related]
14. Oligonucleotide analogue interference with the HIV-1 Tat protein-TAR RNA interaction.
Arzumanov A; Walsh AP; Liu X; Rajwanshi VK; Wengel J; Gait MJ
Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):471-80. PubMed ID: 11563062
[TBL] [Abstract][Full Text] [Related]
15. Doxorubicin inhibits Tat-dependent transactivation of HIV type 1 LTR.
Jeyaseelan R; Kurabayashi M; Kedes L
AIDS Res Hum Retroviruses; 1996 May; 12(7):569-76. PubMed ID: 8743082
[TBL] [Abstract][Full Text] [Related]
16. Identification of ligands for RNA targets via structure-based virtual screening: HIV-1 TAR.
Filikov AV; Mohan V; Vickers TA; Griffey RH; Cook PD; Abagyan RA; James TL
J Comput Aided Mol Des; 2000 Aug; 14(6):593-610. PubMed ID: 10921774
[TBL] [Abstract][Full Text] [Related]
17. Selection of TAR RNA-binding chameleon peptides by using a retroviral replication system.
Xie B; Calabro V; Wainberg MA; Frankel AD
J Virol; 2004 Feb; 78(3):1456-63. PubMed ID: 14722301
[TBL] [Abstract][Full Text] [Related]
18. Nuclear Factor 90(NF90) targeted to TAR RNA inhibits transcriptional activation of HIV-1.
Agbottah ET; Traviss C; McArdle J; Karki S; St Laurent GC; Kumar A
Retrovirology; 2007 Jun; 4():41. PubMed ID: 17565699
[TBL] [Abstract][Full Text] [Related]
19. Exon2 of HIV-2 Tat contributes to transactivation of the HIV-2 LTR by increasing binding affinity to HIV-2 TAR RNA.
Rhim H; Rice AP
Nucleic Acids Res; 1994 Oct; 22(21):4405-13. PubMed ID: 7971271
[TBL] [Abstract][Full Text] [Related]
20. tat regulates binding of the human immunodeficiency virus trans-activating region RNA loop-binding protein TRP-185.
Wu F; Garcia J; Sigman D; Gaynor R
Genes Dev; 1991 Nov; 5(11):2128-40. PubMed ID: 1936997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
